Literature DB >> 26909752

Meta-analysis framework for exact inferences with application to the analysis of rare events.

Guang Yang1, Dungang Liu2, Junyuan Wang3, Min-Ge Xie4.   

Abstract

The usefulness of meta-analysis has been recognized in the evaluation of drug safety, as a single trial usually yields few adverse events and offers limited information. For rare events, conventional meta-analysis methods may yield an invalid inference, as they often rely on large sample theories and require empirical corrections for zero events. These problems motivate research in developing exact methods, including Tian et al.'s method of combining confidence intervals (2009, Biostatistics, 10, 275-281) and Liu et al.'s method of combining p-value functions (2014, JASA, 109, 1450-1465). This article shows that these two exact methods can be unified under the framework of combining confidence distributions (CDs). Furthermore, we show that the CD method generalizes Tian et al.'s method in several aspects. Given that the CD framework also subsumes the Mantel-Haenszel and Peto methods, we conclude that the CD method offers a general framework for meta-analysis of rare events. We illustrate the CD framework using two real data sets collected for the safety analysis of diabetes drugs.
© 2016, The International Biometric Society.

Entities:  

Keywords:  Clinical trial; Confidence distribution; Drug safety; Safety signal detecting; Zero event

Mesh:

Substances:

Year:  2016        PMID: 26909752     DOI: 10.1111/biom.12497

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  2 in total

1.  Real-world Performance of Meta-analysis Methods for Double-Zero-Event Studies with Dichotomous Outcomes Using the Cochrane Database of Systematic Reviews.

Authors:  Yanan Ren; Lifeng Lin; Qinshu Lian; Hui Zou; Haitao Chu
Journal:  J Gen Intern Med       Date:  2019-03-18       Impact factor: 5.128

2.  Accurate confidence intervals for risk difference in meta-analysis with rare events.

Authors:  Tao Jiang; Baixin Cao; Guogen Shan
Journal:  BMC Med Res Methodol       Date:  2020-04-30       Impact factor: 4.615

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.